Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

2008863 citationsJournal Articlebronze Open Access

Authors

XELOX is noninferior to FOLFOX-4 as a first-line treatment for MCRC, and may be considered as a routine treatment option for appropriate patients.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 26, Issue 12, pp. 2006-2012

Field-Weighted Citation Impact: 32.91